Efforts and Challenges paved by India to confront of Corona Virus (COVID-19)

Authors

  • Mohammad Gayoor Khan Department of Pharmacology, Daksh Institute of Pharmaceutical Science, Chhatarpur,Madhya Pradesh, 471001-India
  • Umama Yezdani Department of Pharmacy Practice, MRM College of Pharmacy, Hyderabad, Telangana, 501510 – India
  • Arghya Chakravorty School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014 – India
  • Tanvi Shukla Department of Pharmaceutical Chemistry, NIRMA University, Ahmedabad, Gujarat, 382481 – India

DOI:

https://doi.org/10.3329/bjms.v19i0.48198

Keywords:

Government of India,World Health Organization, Lockdown, Corona, Challenges

Abstract

The clinical range of Covid-19 is a respiratory route infection that varies from Asymptomatic to various clinical conditions such as respiratory failure to multiple organ dysfunction syndromes (MODS). Government administration officials are ramping up many efforts i.e prevention and containing the spread from escalating to the next level, raising the quarantine stations and increase in the laboratory capacity, strengthening surveillance, contact tracing using artificial intelligence (AI) via technology apps. India is Consequently facing many challenges to tackle the pandemic from shortage of medical supply to the devastation of the educational, transportation, job sectors, and healthcare sector, However, pharmaceutical companies taking center stage in the Covid-19 fight, Other pharmaceutical companies(low scale) in India are following suit during the Covid-19 pandemic and using their capabilities to lighten the burden of coronavirus, WHO recommends social distancing and country-wise lockdown are very essential to tackle the coronavirus, the GOI is scheming on how to get back to normalcy, with an actionable exit plan for the states to confront the coronavirus

Bangladesh Journal of Medical Science Vol.19(0) 2020 p. S 88-S 92

Downloads

Download data is not yet available.
Abstract
7
PDF
2

Downloads

Published

2020-07-20

How to Cite

Khan, M. G., Yezdani, U., Chakravorty, A., & Shukla, T. (2020). Efforts and Challenges paved by India to confront of Corona Virus (COVID-19). Bangladesh Journal of Medical Science, 19, S 88–S 92. https://doi.org/10.3329/bjms.v19i0.48198

Issue

Vol 19: 'Special issue on Covid 19' 2020

Section

Review Article

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.